Boston Scientific Seeks To Have $324 Mil. J&J Stent Patent Award Set Aside

Boston Scientific says it may appeal a $324.4 mil. Johnson & Johnson stent patent suit damages award if it is unable to persuade the court to set aside the infringement verdict, arguing that the relevant patents were improperly obtained and are therefore unenforceable.